Abstract
Increasing life expectancy has resulted in an increase in neurodegenerative disorders like Alzheimer’s disease. None of the hypothesis proposed till date explains the exact pathobiology of the disease. It is therefore imperative to understand the underlying mechanisms. Amyloid beta (Aβ) is regarded as the main culprit and maximum therapeutic efforts are centered towards Aβ. This review will discuss about the biosynthesis, the physiological role of Aβ including the pathogenic aggregation of Aβ resulting neurodegenerative cognitive disabilities. Most studies of Alzheimer’s disease have focused on the biochemical mechanisms involved in the neurodegenerative processes triggered by Aβ aggregates. Aβ is generated from mature amyloid precursor protein being metabolized by two competing pathways, α-secretase pathway (non-amyloidogenic pathway) and β-secretase (amyloidogenic pathway). The physiological roles of Aβ reported in neurotrophic properties, neurogenesis, synaptic plasticity, metal ion sequestration and specificity of blood brain barrier. The neuronal injury is the result of Aβ oligomerization and it is reported that oligomerization of Aβ contributes to neurodegeneration in Alzheimer’s disease. The physiological role of Aβ must be considered in the development of medications that intended to decrease its oligomerization forming plaques in a disease like Alzheimer’s disease. The biosynthetic pathways for transport and accumulation of Aβ need to be ascertained as an attempt to develop future strategies for prevention of neurodegenerative disorders.
Similar content being viewed by others
References
Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR (1995) An English translation of Alzheimer’s 1907 paper Uber eineeigenartige Erkankung der Hirnrinde. Clin Anat 8:429–431
Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C (2005) Structure of the cross-beta spine of amyloid-like fibrils. Nature 435:773–778
Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Ann Rev Neurosci 26:267–298
Ramirez-Alvarado M, Merkel JS, Regan L (2000) A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc Natl Acad Sci 97(16):8979–8984
Gandy S (2005) The role of cerebral amyloid β accumulation in common forms of Alzheimer’s disease. J Clin Invest 115:1121–1129
Pietri M (2013) PDK1 decreases TACE-mediated alpha-secretase activity and promotes disease progression in prion and Alzheimer’s diseases. Nat Med 245(654):342–349
Golde TE (2013) Gamma-secretase inhibitors and modulators. Biochem Biophys Acta 356:245–267
Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW (1991) In vitro aging of beta amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563:311–314
Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16:285–298
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356
Korczyn AD (2008) The amyloid cascade hypothesis. Alzheim. Dementia 4:176–178
Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL (2004) Synaptic targeting by Alzheimer’s-related amyloid beta oligomers. J Neurosci 24:10191–10200
Edwards DR, Handsley M, Pennington CJ (2008) The ADAM metalloproteinase’s. Mol Asp Med 29(5):258–289
Shoji M (1992) Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258(5079):126–129
Chang KA, Suh YH (2010) Possible roles of amyloid intracellular domain of amyloid precursorprotein. BMB Rep 43(10):656–663
Zhang H (2011) Proteolytic processing of Alzheimer’s beta-amyloid precursor protein. J Neurochem 1(1):9–21
Vanessa de Jesus R, Guimarães FM, Diniz BS, Forlenza OV (2009) Neurobiological pathways to Alzheimer’s disease: amyloid-beta, Tau protein or both? Dement Neuropsychol 24(1):234–245
Ko¨gel D, Deller T, Behl C (2011) Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging. Exp Brain Res 2211:121–143
Wilquet V, De Strooper B (2004) Amyloid-beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol 14:582–588
Lazo ND, Maji SK, Fradinger EA, Bitan G, Teplow DB (2004) The amyloid β protein. Am J Pathol 56:384–491
Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer’s disease. Arch Biochem Biophys 301:41–52
Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, Ball MJ (1993) Beta-Amyloid is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci 90:10836–10840
Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y (1995) Amyloid beta protein (A beta) deposition: Abeta 42(43) precedes Abeta 40 in Down syndrome. Ann Neurol 37:294–299
Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y (1994) High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 145:452–460
Plant LD (2003) The production of amyloid beta peptide is a critical requirement for the plaque-associated changes in amyloid-beta metabolism and half-life. J Neurosci 23(13):5531–5535
Cirrito JR (2003) In vivo assessment of brain interstitial fluid with micro dialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. J Neurosci 23(26):8844–8853
Atwood CS (2003) Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res Brain Res Rev 43(1):1–16
Hughes JR (1958) Post-tetanic potentiation physiological reviews. Exp Brain Res 34(1):91–113
Walsh DM (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416(6880):535–539
Nalivaeva NN, Turner AJ (2013) The amyloid precursor protein: a biochemical enigma in brain development, function and disease. FEBS Lett 587(13):2046–2054
Kohli BM (2012) Interactome of the amyloid precursor protein APP in brain reveals a protein network involved in synaptic vesicle turnover and a close association with Synaptotagmin-1. J Proteome Res 11(8):4075–4090
Octave JN (2013) From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein. J Neurochem 126(2):183–190
Puzzo D (2011) Endogenous amyloid-beta is necessary for hippocampal synaptic plasticity and memory. Ann Neurol 69(5):819–830
Smith DG, Cappai R, Barnham KJ (2007) The redox chemistry of the Alzheimer’s disease amyloid beta peptide. Biochem Biophys Acta 1768(8):1976–1990
Baruch R, Fischer B (2009) Abeta 40 either soluble or aggregated is a remarkably potent antioxidant in cell-free oxidative systems. Biochemistry 48(20):4354–4370
Kontush A, Atwood CS (2004) Amyloid-beta: phylogenesis of a chameleon. Brain Res Rev 46(1):118–120
Curtain C (2001) Alzheimer’s disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem 276(23):20466–20473
Huang X (1999) The A beta peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38(24):7609–7616
Zou K et al (2002) A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J Neurosci 22(12):4833-4841
Birbrair Alexander (2013) Skeletal muscle neural proginetor cells exhibit properties of NG2-glia. Exp Cell Res 319(1):45–63
Jin K, Peel AL, Mao XO (2004) Increased hippocampal neurogenesis in Alzheimer’s disease. Proc Natl Acad Sci 101(1):343–347
Mu Y, Gage F (2011) Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Mol Neurodegener 6:85
Schulte-Herbruggen MC, Scherubl Hellweg (2008) Neurotrophins: from pathophysiology to treatment in Alzheimer’s disease. Curr Alzheimer Res 5(1):38–44
Lopez-Toledano MA, Shelanski ML (2004) Neurogenic effect of beta-amyloid peptide in the development of neural stem cells. J Neurosci 24(23):5439–5444
Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Nature Science 250(4978):279–282
Jan A, Gokce O, Luthi-Carter R, Lashuel HA (2008) The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J Biol Chem 283:28176–28189
Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB (2003) Amyloid beta protein (Abeta) assembly: Abeta40 and Abeta42 oligomerize through distinct pathways. Proc Nat Aca Sci 100:330–335
Harper JD, Lansbury PT (1997) Models of amyloid seeding in Alzheimer’s disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66:385–407
Taylor BM, Sarver RW, Fici G, Poorman RA, Lutzke BS, Molinari A (2003) Spontaneous aggregation and cytotoxicity of the β-amyloid Aβ1-40: a kinetic model. Biochemistry 22:31–40
LaFerla (2002) Calcium dyshomeostasis and intracellular signaling in Alzheimer’s disease. Nature Review Neurosci 3(1):862–872
Wang HY, Lee DHS, Andrea MR, Peterson PA, Shank RP, Reitz AB (2000) β-Amyloid (1-42) binds to alpha 7 nicotinic acetylcholine receptor with high affinity: implications for Alzheimer’s disease pathology. J Biol Chem 275:5626–5632
Arispe N, Diaz JC, Simakova O (2007) Aβ ion channels: prospects for treating Alzheimer’s disease with Aβ channel blockers. Biochim Biophys Acta 1768:1952–1965
De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST (2007) Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590–11601
Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280:17294–17300
Kelly BL, Ferreira A (2006) βAmyloid-induced dynamin -1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J Biol Chem 281:28079–28089
Deshpande A, Kawai H, Metherate R, Glabe CG, Busciglio J (2009) A role for synaptic zinc in activity-dependent Aβ oligomer formation and accumulation at excitatory synapses. J Neurosci 29:4004–4015
Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D (2009) Soluble oligomers of amyloid Aβ protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62:788–801
Shankar GM, Blood good BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866–2875
Sanz-Blasco S, Valero RA, Rodríguez-Crespo I, Villalobos C, Núñez L (2008) Mitochondrial Ca2+ overload underlies Aβ oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs. PLoS One 3(1):2718–2809
Pfrieger FW (2005) Cholesterol: a Major dietary factor regulating formation of amyloid beta. Biochim Biophys Acta 1610:271–280
Bodovitz S, Klein WL (1996) Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 271:4436–4440
Ikezu T, Trapp BD, Song KS, Schlegel A, Lisanti MP, Okamoto T (1998) Caveolae, plasma membrane microdomains for alpha-secretase mediated processing of the amyloid precursor protein. J Biol Chem 273:10485–10495
Acknowledgments
The authors are thankful to Shoolini University, Solan, HP for providing facilities of data base for exhaustive literature survey.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared no conflict of interests.
Rights and permissions
About this article
Cite this article
Gupta, A., Goyal, R. Amyloid beta plaque: a culprit for neurodegeneration. Acta Neurol Belg 116, 445–450 (2016). https://doi.org/10.1007/s13760-016-0639-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-016-0639-9